About

Dr. Mark E. Borowsky is a gynecologic oncologist whose research focuses on advancing minimally invasive surgical techniques, particularly robotic-assisted surgery, for the treatment of gynecologic malignancies. His work has significantly contributed to understanding and improving outcomes in endometrial and cervical cancer care. Dr. Borowsky’s major contributions include investigating port-site metastasis following robotic radical hysterectomy for cervical cancer, a critical safety concern that has informed surgical protocols. He has also led pivotal studies on venous thromboembolism (VTE) prophylaxis after robotic staging for endometrial cancer, comparing single-dose versus extended postoperative enoxaparin to optimize patient safety. Additionally, his research on sentinel lymph node (SLN) sampling using indocyanine green dye has validated its safety and sensitivity in robot-assisted staging for both endometrial cancer and complex atypical endometrial hyperplasia, helping to reduce the need for more extensive lymphadenectomy. With over 19 citations across his most-cited works, Dr. Borowsky’s research continues to shape evidence-based practices in robotic gynecologic oncology, directly impacting surgical decision-making and postoperative care.

Research Focus

Key Achievements

3
H-Index
4
Papers
19
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Port-site metastasis following robotic-assisted radical hysterectomy for squamous cell cervical cancer
9 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Christiana Care Health System, Gynecologic Oncology Group, Hackensack Meridian Health, Jersey Shore University Medical Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago